ArticleFrontiers in oncology2026
Prediction of tumor progression in intermediate and advanced hepatocellular carcinoma undergoing TACE combined with targeted immunotherapy.
Lina Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.